When total cholesterol is 300 mg/dL, HDL is 25 mg/dL, and triglycerides are 150 mg/dL, what is the value of LDL?
- 55
- 95
- 125
- 245
ANS
Total cholesterol = HDL + LDL + TG/5
Therefore LDL=Total cholesterol-HDL-TG/5
LDL=300-25-30
LDL=245mg/dl
LDL=300-25-30
LDL=245mg/dl
Lipids

- HDL β 1 (A1 - not transferrable), 2 (C2), 3 (E)
- VLDL/LDL β 100 (B100) + HDL
- Chylomicrons β 48 (B48) + HDL
Friedweld formula
- Total cholesterol = HDL + LDL + TG/5
Apolipoprotein | Present in |
Apo AI | HDL |
Apo CII | Chylomicron, VLDL, IDL, HDL |
Apo E | Chylomicron, Remnant, VLDL, IDL, HDL |
Bββ | Chylomicron, Remnant |
Bβββ | VLDL, IDL, LDL |
Fatty Acid Transport
- Fatty acids need a carrier, Carnitine, for transport
- to cross the inner mitochondrial membrane for oxidation
Rate Limiting Enzymes of Lipid Metabolism Pathways
Glucose Pathways | Rate Limiting Enzyme |
Glycolysis | Phosphofructokinase-1 |
TCA Cycle / Krebs cycle | Isocitrate dehydrogenase |
Gluconeogenesis | Fructose-1,6-bisphosphatase |
Glycogen Synthesis | Glycogen synthase |
Glycogenolysis | Glycogen phosphorylase |
HMP Shunt (PPP) | Glucose-6-phosphate dehydrogenase |
Lipid Pathways | γ
€ |
Fatty acid synthesis | Acetyl CoA carboxylase |
Fatty acid oxidation | Carnitine acyl transferase 1 |
Cholesterol synthesis | HMG CoA Reductase β³ Statins inhibit this enzyme |
Ketone body synthesis | HMG CoA Synthase > HMG CoA Lyase |
Bile acid synthesis | 7Ξ± hydroxylase (Vit C) |
Note:
Fate of Acetyl CoA | Enzyme | Note |
β³ Fatty acid synthesis | Acetyl CoA Carboxylase | β’ Stored as Triacylglycerol |
β³ Cholesterol synthesis | HMG-CoA reductase | β’ In fed state β’ Stored as Cholesterol ester β’ RLE in cholesterol synthesis β’ β by statins |
β³ KB Synthesis | HMG-CoA lyase | β’ In Starvation |
- NOTE:
- HMG-CoA synthase
- Common in both cholesterol and KB synthesis
- RLE in ketone body synthesis
Hyperlipoproteinemias (Friedrickson's Classification)
γ
€ | Type | Defect | β Lipid / Lipoprotein | Clinical Features |
1 | Familial Chylomicronemia | LPL deficiency or Apo C-II deficiency | β Chylomicrons, β TG | β’ Pancreatitis β’ eruptive xanthomas β’ lipemia retinalis β’ Creamy supernatant, clear plasma |
2a | Familial Hypercholesterolemia | LDL receptor deficiency (or ApoB-100 defect) | β LDL, β Cholesterol | β’ Premature atherosclerosis β’ tendon xanthomas β’ corneal arcus |
2b | Combined Hyperlipidemia | LDL receptor & ApoB-100 defect (β VLDL production) | β LDL + VLDL | β’ Atherosclerosis |
3 | Familial Dysbetalipoproteinemia | ApoE defect | β Chylomicron remnants + IDL | β’ Palmar & tuberoeruptive xanthomas β’ premature atherosclerosis β’ Broad beta bands |
4 | Familial Hypertriglyceridemia | Overproduction of VLDL | β VLDL, β TG | β’ Acute Pancreatitis β’ obesity β’ diabetes association |
- There are six types.
- They are classified into three categories by lipid elevation:
- Hypercholesterolemia.
- Hypertriglyceridemia.
- Both.
Clinical Features of Hyperlipoproteinemias
- Hypercholesterolemia presents with:
- Tendon Xanthomas.
- Small eruptive lesions along tendon attachments.
- Pronounced on knuckles or ankles.
- Accelerated Atherosclerosis.

- Hypertriglyceridemia presents with:
- Eruptive xanthomas.
- Tinier than tendon xanthomas.
- Present on extensive surfaces of limbs, especially elbows.
- Recurrent pancreatitis.
- Lipemia retinalis.
- Isolated elevated Hypercholesterolemia:
- Type 2a
- Chola β DolA β 2a
- Isolated elevated Triglycerides:
- Type 1, Type 4, Type 5.
- TriG β 3 β 1, 4, 5
- Elevated both Cholesterol and Triglycerides:
- Type 2b, Type 3.
- Dola + Tri β 2b + 3
- Autosomal dominant
- Type 2a, Type 4 and Type 5
- Mnemonic:
- Type 1 β 1st β from intestine β β TGA and chylomicrons
- Type 2a β 2nd β from liver β β Cholesterol
- Type 2b & 3 β both β TGA and cholesterol
Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)


- It is an autosomal dominant
- Only elevated Cholesterol.
- Defect of the LDL receptor or Apo B100
- prevents LDL clearance
- LDL accumulation
- Hypercholesterolemia.
Type I Hyperlipoproteinemia (Familial Chylomicronemia syndrome)



- Autosomal recessive
- Caused by a defect of Apo CII or Lipoprotein lipase (LPL).
- Chylomicrons:
- Transport dietary TGA from the intestine to extrahepatic tissues.
- Are drained by lymphatics, enter the thoracic duct, then systemic circulation.
- Contain apoproteins:
- Apo CII,
- Apo E,
- Apo B48.
Metabolism:
- Apo CII β activates LPL, which is held to vessel walls by Heparan sulphate.
- LPL cleaves chylomicron triacylglycerol into glycerol and fatty acids.
- Fatty acids enter extrahepatic tissues.
- Glycerol is used by the liver.
- Chylomicrons become remnants after losing triacylglycerol.
- Remnants are accepted by liver LDL or remnant receptors.
- LDL receptor β accepts Apo E or Apo B100
- Remnant receptor β accepts Apo E
Defects in Apo CII or LPL
- prevent chylomicron metabolism.
- This leads to chylomicron accumulation.
- Causes Familial Chylomicronemia syndrome.
Features:
- Massive hypertriglyceridemia.
- Recurrent pancreatitis.
- Eruptive xanthoma.
- Lipemia retinalis.
Diagnosis:
- Check lipoprotein lipase enzyme activity.
- Inject Heparin to detach LPL into the blood.
- ββ post-heparinised LPL activity confirms the diagnosis.
Type III Hyperlipoproteinemia /
Familial Dysbetalipoproteinemia (D - E)



- Homozygous E2 mutation.
- Normal: Homozygous E3 allel
- β Apo E defect.
- Mnemonic:
- Three β Eee (Apo E)
- Dys beta β bad β beat in palm (Palmaris striae, palmaris xanthoma) with a tube β erupted (Tubero eruptive) β 2 times (E2) Cried EEEee (Apo E) β grapes (bunch of grapes)
- Results in elevation of both cholesterol and triglycerides.
- Cerebral amyloid disease?
Also called:
- Remnant disease
- as remnant lipoproteins are not cleared.
- Broad Beta disease.
- Lipoprotein Electrophoresis:
- Broad Beta Band (Pathognomic)
- Familial Dysbetalipoproteinemia.
Dermatological pathognomic feature:
- Palmar eruptive xanthomas.
- Palmaris Xanthoma striae
- yellowish discoloration of palmar creases

Abetalipoproteinemia (A - B)
- Mnemonic: A beta () β Beta illa (Failure to thrive) β Beta ye Akkan (Acanthocytes) MTP (MTP gene) cheyth
- Body rash (Petechial rash) ulla akkan
- Fat (Lipid laden enterocytes on biopsy)
- Last β Akkanu bleeding (Vitamin Kβββ) vann, kazcha poi (Retinitis pigmentosa)
- Vitamin E tratment

- Autosomal recessive (AR)
- Mutation in
- MTP gene in intestine
- (Microsomal Triglyceride Transfer Protein)
- β ββ synthesis of apo B48 and B100 lipoproteins
- β absence of chylomicrons, LDL, VLDL
- Lipoproteins β:
- Chylomicrons, VLDL, LDL
Clinical features:
- Infancy:
- Fat malabsorption,
- steatorrhea,
- failure to thrive
Later:
- Retinitis pigmentosa

- Spinocerebellar ataxia
- Acanthocytosis

- Petechial rash

- Bleeding manifestations
- due to β fat-soluble vitamins like K and E
Diagnosis:
- Lipid-laden enterocytes on biopsy

Treatment:
- Restrict long-chain fatty acids;
- high-dose vitamin E
Retinitis Pigmentosa

Mnemonic:
- Bony spicules
- Pigmentary epithelium
- Donut scotoma/tunnel vision
- Night β Nyctalopia
- Moon β Lawrence moon biedl syndrome
- Moon has law in bed
Β
Features
- Rod-cone dystrophy (Rods > cones affected).
- M/c inheritance: Autosomal recessive (M/c hereditary fundus dystrophy)
- Cause: ββ Docosahexanoic acid
- Clinical Features:
- Nyctalopia.
- Ring/donut scotoma/tunnel visionΒ (rods affected).
- Bony spicule pigmentation.
- Arteriolar attenuation
- Waxy, pale optic disc.
- Systemic association:
- Lawrence-Moon-Biedl syndrome.
- Usher Sx β RP + SNHL
- Treatment:
- Genetic counselling (no specific treatment).
- ERG Interpretation:
- a wave (photoreceptors)
- b wave (bipolar & Mullerβs cells)
- c wave (pigment epithelium metabolic activity)
- Abnormal ERG in Retinitis Pigmentosa
- Rods > cons photoreceptors affected
- a wave absent

Tangier's Disease:


- Characterised by orange-coloured tonsils.
- Cholesterol esters accumulate in extrahepatic tissues, causing:
- Greyish-orange tonsils.
- Hepatosplenomegaly.
- Mononeuritis multiplex.
- ABC students drink Tang β don't get A1 β cant multiply
- Caused by a mutation in ABC1 (ATP Binding Cassette transporter 1).
- Key Characteristic:
- SignificantlyΒ reduced levels of apo A1β very low HDL levels.
Profile Component | Level |
HDL | ββ |
LDL | β |
TAG | β |
Total Cholesterol | Normal/Low |
Apo A1 | ββ |
Fish Eye Disease β LpX

- Partial LCAT deficiency / Hypo alpha lipoproteinemia (β LDL)
- LCAT
- discoidal HDL β spheroidal HDL
- Deficiency β ββ Discoidal HDL
- Discoidal HDL β lamellar structure β cannot move
- Electrophoresis
- Appears as band at application point = Lipoprotein X (LpX)
- Features
- No anemia (unlike full LCAT deficiency)
- Chronic Kidney Disease
- LpX accumulates in mesangium
- Corneal opacity (fish eye disease)
- Cholesterol ester accumulation
- NOTE
- Norumβs disease
- Complete LCAT deficiency
- Nooru (100) β complete
HDL

- Highest Apoprotein concentration
- Site: Liver & Intestine
- Steps
- Apo AI activates LCAT
- Formation of Cholesterol Esters
- Discoidal HDL β Mature/Spherical HDL3 β Delivers cholesterol to liver
- Reverts to HDL3
- Function: Facilitates reverse cholesterol transport
Lipoprotein electrophoresis
Q. Lipoprotein electrophoresis of a patient presenting with chronic kidney disease, corneal opacity, low HDL is provided here. The band identified as A and the disorder is?

- (Image showing Lipoprotein electrophoresis with bands and band A at application point).
- A. M band and Multiple Myeloma.
- B. Chylomicron and Type I Hyperlipoproteinemia.
- C. LDL and Type II Hyperlipoproteinemia.
- D. LpX and complete LCAT deficiency.
Explanation:
- Arrow = Point of application.
- Farthest band = Alpha band (HDL).
- Band A is at the arrow mark in the patient's pattern.
- LCAT deficiency:
- Presence of Lipoprotein X (LpX)
- LpX band at the point of application.
- Findings:
- Low HDL β Hypo alpha lipoproteinemia
- Corneal opacity β Fish eye disease


- Done on a glass slide
- Support medium: Agarose
- Serum lipoprotein applied at one end
- Glass slide connected to electrical supply
- Negative electrode:
- near application point
- Positive electrode:
- opposite point
- On current supply β lipoproteins move toward oppositely charged electrode

Migration depends on
- Number of negative charges
- More charges β more rapid movement
- Size
- Larger particles move poorly
VLDL
- Endogenous TAG
LDL
- Max Cholesterol
Alpha band / HDL
- Moves farthest
- Min TAG
- Max PL
- Max protein
- Has more negative charges
Chylomicron band
- Moves closest (due to huge size)
- Maximum TAG
- Fasting sample required
- Normally absent
- It is a product of dietary triacylglycerol
- Presence indicates:
- Patient not fasting
- Or chylomicron elevated β Familial Chylomicronemia Syndrome
Obstructive jaundice
- Bile salt concentration in circulation β
- Forms lamellar structure
- Appears as band at application point
Other normal bands
- Beta band β LDL
- Pre-Beta band β VLDL
Remnant concentration
- Normally too low to detect
- If present β after beta band
- Type III hyperlipoproteinemia / remnant disease
- Remnant band significant
- Appears as broad beta band
